20 Dec, EOD - Indian

SENSEX 78041.59 (-1.49)

Nifty 50 23587.5 (-1.52)

Nifty Bank 50759.2 (-1.58)

Nifty IT 43771.05 (-2.63)

Nifty Midcap 100 56906.75 (-2.82)

Nifty Next 50 68702.65 (-2.72)

Nifty Pharma 22501.85 (-0.86)

Nifty Smallcap 100 18714.3 (-2.19)

20 Dec, EOD - Global

NIKKEI 225 38701.9 (-0.29)

HANG SENG 19720.7 (-0.16)

S&P 6008.5 (1.05)

Login/Signup

You are Here : Home > Research

01-Feb-2024

Sun Pharmaceuticals Industries

OP up 15.75%

'For the quarter ending Dec 2023, consolidated Net sales (including other operating income) of Sun Pharmaceuticals Industries has increased 10.14% to Rs 12380.7 crore compared to quarter ended Dec 2022.  Operating profit margin has jumped from 26.72% to 28.08%, leading to 15.75% rise in operating profit to Rs 3,476.83 crore.  Raw material cost as a % of total sales (net of stock adjustments) decreased from 16.63% to 14.07%.   Purchase of finished goods cost fell from 7.93% to 6.56%.   Employee cost increased from 18.21% to 19.45%.   Other expenses rose from 30.37% to 31.31%.   

Other income rose 43.89% to Rs 250.2 crore.  PBIDT rose 17.29% to Rs 3727.03 crore.  Provision for interest fell 24.79% to Rs 34.73 crore.  

PBDT rose 17.91% to Rs 3692.3 crore.  Provision for depreciation fell 5.73% to Rs 622.14 crore.  

Profit before tax grew 24.22% to Rs 3,07...



Pleaselogin & subscribe to view the full report.

More Reports
More Reports View Company Information